Finanças

Notícias Discussões Sinais técnicos Previsão Sazonais

Lucro líquido antes das operações descontinuadas de Knight Therapeutics Inc.

Dados anuais

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

TTM

‪‪−34,00 M‬‬

‪‪−17,00 M‬‬

‪0,00‬

‪‪17,00 M‬‬

‪‪34,00 M‬‬

Período

Valor

Variação

Variação %

TTM

‪‪−22,71 M‬‬

‪‪−10,01 M‬‬

‪−78,79‬%

2023

‪‪−12,70 M‬‬

+‪‪9,35 M‬‬

+‪42,40‬%

2022

‪‪−22,05 M‬‬

‪‪−34,44 M‬‬

‪−277,94‬%

2021

‪‪12,39 M‬‬

‪‪−20,63 M‬‬

‪−62,47‬%

2020

‪‪33,02 M‬‬

+‪‪21,82 M‬‬

+‪194,95‬%

2019

‪‪11,19 M‬‬

‪‪−6,44 M‬‬

‪−36,50‬%

2018

2017

2016

2015

2014

Dados trimestrais

Q1 '17

Q2 '17

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−24,00 M‬‬

‪‪−16,00 M‬‬

‪‪−8,00 M‬‬

‪0,00‬

‪‪8,00 M‬‬

Período

Valor

Variação

Variação %

Q3 '24

‪‪62,82 K‬‬

+‪‪1,48 M‬‬

—

Q2 '24

‪‪−1,42 M‬‬

+‪‪1,94 M‬‬

+‪57,72‬%

Q1 '24

‪‪−3,36 M‬‬

+‪‪15,00 M‬‬

+‪81,72‬%

Q4 '23

‪‪−18,35 M‬‬

‪‪−25,41 M‬‬

‪−360,05‬%

Q3 '23

‪‪7,06 M‬‬

+‪‪5,67 M‬‬

+‪408,45‬%

Q2 '23

‪‪1,39 M‬‬

+‪‪4,30 M‬‬

—

Q1 '23

‪‪−2,91 M‬‬

+‪‪8,29 M‬‬

+‪74,02‬%

Q4 '22

‪‪−11,20 M‬‬

‪‪−12,35 M‬‬

‪‪−1,07 K‬‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19

Q3 '19

Q2 '19

Q1 '19

Q4 '18

Q3 '18

Q2 '18

Q1 '18

Q4 '17

Q3 '17

Q2 '17

Q1 '17